- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Affecting 70-80% of patients undergoing chemotherapy, chemotherapy-induced nausea and vomiting (CINV) is one of chemotherapy's most debilitating side effects, often attributed as a leading cause of premature discontinuation of cancer treatment.
According to our latest study, the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size was valued at USD 2431.4 million in 2022 and is forecast to a readjusted size of USD 2182.5 million by 2029 with a CAGR of -1.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs key players include Haisco, Merck, Mundipharma, Qilu Pharma, Heron Therapeutics, Teva, etc. Global top six manufacturers hold a share about 30%.
North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, both have a share about 60 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 70%. And in terms of application, the largest application is Acute CINV, followed by Delayed CINV and Breakthrough CINV.
This report is a detailed and comprehensive analysis for global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Heron Therapeutics, Merck, Eisai, Mundipharma and Qilu Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
5-HT3 Inhibitors
NK1 Inhibitors
Others
Market segment by Application
Acute CINV
Delayed CINV
Breakthrough CINV
Others
Major players covered
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, with price, sales, revenue and global market share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs from 2018 to 2023.
Chapter 3, the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs.
Chapter 14 and 15, to describe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 5-HT3 Inhibitors
1.3.3 NK1 Inhibitors
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Acute CINV
1.4.3 Delayed CINV
1.4.4 Breakthrough CINV
1.4.5 Others
1.5 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size & Forecast
1.5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (2018-2029)
1.5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Heron Therapeutics
2.1.1 Heron Therapeutics Details
2.1.2 Heron Therapeutics Major Business
2.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.1.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Heron Therapeutics Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.2.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 Eisai
2.3.1 Eisai Details
2.3.2 Eisai Major Business
2.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.3.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Eisai Recent Developments/Updates
2.4 Mundipharma
2.4.1 Mundipharma Details
2.4.2 Mundipharma Major Business
2.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mundipharma Recent Developments/Updates
2.5 Qilu Pharma
2.5.1 Qilu Pharma Details
2.5.2 Qilu Pharma Major Business
2.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.5.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Qilu Pharma Recent Developments/Updates
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.6.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Recent Developments/Updates
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.7.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novartis Recent Developments/Updates
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Roche Recent Developments/Updates
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Mylan Recent Developments/Updates
2.10 Baxter
2.10.1 Baxter Details
2.10.2 Baxter Major Business
2.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.10.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Baxter Recent Developments/Updates
2.11 GSK
2.11.1 GSK Details
2.11.2 GSK Major Business
2.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.11.4 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 GSK Recent Developments/Updates
2.12 Helsinn
2.12.1 Helsinn Details
2.12.2 Helsinn Major Business
2.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.12.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Helsinn Recent Developments/Updates
2.13 Southwest Pharma
2.13.1 Southwest Pharma Details
2.13.2 Southwest Pharma Major Business
2.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.13.4 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Southwest Pharma Recent Developments/Updates
2.14 Haisco
2.14.1 Haisco Details
2.14.2 Haisco Major Business
2.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.14.4 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Haisco Recent Developments/Updates
2.15 Sun Pharma
2.15.1 Sun Pharma Details
2.15.2 Sun Pharma Major Business
2.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
2.15.4 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sun Pharma Recent Developments/Updates
3 Competitive Environment: Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Manufacturer
3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer Market Share in 2022
3.5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Overall Company Footprint Analysis
3.5.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Region Footprint
3.5.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Company Product Type Footprint
3.5.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region
4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Region (2018-2029)
4.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value (2018-2029)
4.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value (2018-2029)
4.5 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2029)
5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Type (2018-2029)
5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2029)
6.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Application (2018-2029)
6.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2029)
7.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2029)
7.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country
7.3.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country
8.3.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region
9.3.1 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2029)
10.2 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2029)
10.3 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country
10.3.1 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country
11.3.1 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers
12.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
12.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
13.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Process
13.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Typical Distributors
14.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Heron Therapeutics Major Business
Table 5. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 6. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Heron Therapeutics Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 11. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Recent Developments/Updates
Table 13. Eisai Basic Information, Manufacturing Base and Competitors
Table 14. Eisai Major Business
Table 15. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 16. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Eisai Recent Developments/Updates
Table 18. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 19. Mundipharma Major Business
Table 20. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 21. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mundipharma Recent Developments/Updates
Table 23. Qilu Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Qilu Pharma Major Business
Table 25. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 26. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Qilu Pharma Recent Developments/Updates
Table 28. Teva Basic Information, Manufacturing Base and Competitors
Table 29. Teva Major Business
Table 30. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 31. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Teva Recent Developments/Updates
Table 33. Novartis Basic Information, Manufacturing Base and Competitors
Table 34. Novartis Major Business
Table 35. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 36. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novartis Recent Developments/Updates
Table 38. Roche Basic Information, Manufacturing Base and Competitors
Table 39. Roche Major Business
Table 40. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 41. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Roche Recent Developments/Updates
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Major Business
Table 45. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 46. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Mylan Recent Developments/Updates
Table 48. Baxter Basic Information, Manufacturing Base and Competitors
Table 49. Baxter Major Business
Table 50. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 51. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Baxter Recent Developments/Updates
Table 53. GSK Basic Information, Manufacturing Base and Competitors
Table 54. GSK Major Business
Table 55. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 56. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. GSK Recent Developments/Updates
Table 58. Helsinn Basic Information, Manufacturing Base and Competitors
Table 59. Helsinn Major Business
Table 60. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 61. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Helsinn Recent Developments/Updates
Table 63. Southwest Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Southwest Pharma Major Business
Table 65. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 66. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Southwest Pharma Recent Developments/Updates
Table 68. Haisco Basic Information, Manufacturing Base and Competitors
Table 69. Haisco Major Business
Table 70. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 71. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Haisco Recent Developments/Updates
Table 73. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Sun Pharma Major Business
Table 75. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services
Table 76. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sun Pharma Recent Developments/Updates
Table 78. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Manufacturer (2018-2023) & (M Units)
Table 79. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Site of Key Manufacturer
Table 83. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Company Product Type Footprint
Table 84. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Company Product Application Footprint
Table 85. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs New Market Entrants and Barriers to Market Entry
Table 86. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Region (2018-2023) & (M Units)
Table 88. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Region (2024-2029) & (M Units)
Table 89. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2023) & (M Units)
Table 94. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2024-2029) & (M Units)
Table 95. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2023) & (M Units)
Table 100. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2024-2029) & (M Units)
Table 101. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2023) & (M Units)
Table 106. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2024-2029) & (M Units)
Table 107. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2023) & (M Units)
Table 108. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2024-2029) & (M Units)
Table 109. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Country (2018-2023) & (M Units)
Table 110. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Country (2024-2029) & (M Units)
Table 111. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2023) & (M Units)
Table 114. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2024-2029) & (M Units)
Table 115. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2023) & (M Units)
Table 116. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2024-2029) & (M Units)
Table 117. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Country (2018-2023) & (M Units)
Table 118. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Country (2024-2029) & (M Units)
Table 119. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2023) & (M Units)
Table 122. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2024-2029) & (M Units)
Table 123. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2023) & (M Units)
Table 124. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2024-2029) & (M Units)
Table 125. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Region (2018-2023) & (M Units)
Table 126. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Region (2024-2029) & (M Units)
Table 127. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2023) & (M Units)
Table 130. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2024-2029) & (M Units)
Table 131. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2023) & (M Units)
Table 132. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2024-2029) & (M Units)
Table 133. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Country (2018-2023) & (M Units)
Table 134. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Country (2024-2029) & (M Units)
Table 135. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2018-2023) & (M Units)
Table 138. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Type (2024-2029) & (M Units)
Table 139. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2018-2023) & (M Units)
Table 140. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Application (2024-2029) & (M Units)
Table 141. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Region (2018-2023) & (M Units)
Table 142. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity by Region (2024-2029) & (M Units)
Table 143. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Raw Material
Table 146. Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Raw Materials
Table 147. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Typical Distributors
Table 148. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Typical Customers
List of Figures
Figure 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Picture
Figure 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value Market Share by Type in 2022
Figure 4. 5-HT3 Inhibitors Examples
Figure 5. NK1 Inhibitors Examples
Figure 6. Others Examples
Figure 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value Market Share by Application in 2022
Figure 9. Acute CINV Examples
Figure 10. Delayed CINV Examples
Figure 11. Breakthrough CINV Examples
Figure 12. Others Examples
Figure 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity (2018-2029) & (M Units)
Figure 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 55. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers
Figure 76. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
Figure 77. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in 2022
Figure 80. Manufacturing Process Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 81. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
